The RNASEH2A gene helps cells remove misplaced RNA building blocks from DNA so your genetic material stays stable as cells grow and divide. When this gene does not work properly, DNA damage and false danger signals can build up, which may trigger inflammation and affect the brain, skin, and development. Harmful variants in the RNASEH2A gene can cause Aicardi-Goutières syndrome, a rare inherited condition that often begins in infancy or childhood. RNASEH2A is mainly known in medical genetics rather than public culture.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for making proteins, the working parts of cells. Others mainly help determine when certain processes happen, where they take place, and how strongly they operate. Taken together, genes affect how the body develops and works, and they can also shape how you respond to food, stress, or medications. To go into this topic in more detail, you can find more in the LearnHub.
Overview
RNASEH2AGene function
What if the gene works
The RNASEH2A gene helps cells remove misplaced RNA pieces from DNA. This supports DNA copying and repair and helps keep genetic information stable.
Risk
What if the gene does not work
More disruptive variants in the RNASEH2A gene can cause Aicardi-Goutières syndrome, an inherited condition that often begins in infancy with brain inflammation, developmental problems, and stiffness or weakness. Milder variants may lead to later onset or less severe features.
Treatment
What does that mean for your treatment
At present, no RNASEH2A-specific treatment or management approach is established for people with a pathogenic variant in the RNASEH2A gene. RNASEH2A is being studied in early cancer research as a possible biomarker and drug target, but this has not changed routine care.
Conditions associated with RNASEH2A
Gene function
What if the gene works
Your cells are constantly copying DNA and clearing away stray RNA along the way. The RNASEH2A gene helps manage this cleanup so genetic material stays orderly and usable. It works as part of a small enzyme team that removes RNA where it should not remain in DNA. Understanding what the RNASEH2A gene does in your cells helps explain how routine cell maintenance stays on track.
Inside a small enzyme team, RNASEH2A helps remove RNA from mixed RNA-DNA strands that appear during normal cell activity. This clears temporary leftovers so DNA can be used and maintained more smoothly.
Your cells can place an RNA building block into DNA by mistake while copying genetic material. The RNASEH2A gene helps cut out these misplaced pieces so the DNA returns to its usual form.
By clearing mixed strands and stray RNA pieces, this gene supports steady DNA copying and routine DNA repair. That helps cells keep their genetic instructions organized from one cell cycle to the next.
What is a variant?
Within a gene, a genetic variant is a small difference in the DNA sequence. These differences are common and contribute to normal human diversity, such as differences in appearance, metabolism, or how the body responds to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. In some situations, however, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the RNASEH2A gene can change the protein’s active site, make it less stable, or stop it from fitting properly into the RNase H2 enzyme complex. This is how variants in the RNASEH2A gene affect protein function: cells remove RNA from mixed RNA-DNA material less efficiently. Milder variants may leave some activity, while more severe variants can cause a greater loss of function and are linked to earlier or more marked features of Aicardi-Goutières syndrome.
How variants are linked to conditions
Pathogenic variants in the RNASEH2A gene cause Aicardi-Goutières syndrome type 4, a rare inherited condition that often begins in infancy or early childhood. The clearest link between RNASEH2A gene variants and Aicardi-Goutières syndrome is seen when a person has disease-causing variants in both copies of the gene. Some people also have features that overlap with lupus-like inflammation, including skin or immune system findings.
A variant is not necessarily a diagnosis
Genetic variants are a normal feature of human biology and are common in the general population. Most have no direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce risk related to the RNASEH2A gene. For many living with disease-causing changes in both copies of RNASEH2A, the chance of developing the related condition is mainly set by the genetic change itself rather than lifestyle or environmental factors.
Inheritance of RNASEH2A variants
RNASEH2A-related conditions with a well-established inheritance pattern are inherited in an autosomal recessive way. This means a child usually inherits one RNASEH2A gene variant from each parent. When both parents carry one variant, each pregnancy has a 25% chance of resulting in a child with the condition, a 50% chance of resulting in a child who is a carrier, and a 25% chance of resulting in a child who inherits neither variant. In practical terms, this is how RNASEH2A gene variants are inherited in the condition most clearly linked to this gene.
What does my RNASEH2A result mean for my family?
For families with a disease-causing RNASEH2A change, the pattern is usually recessive, which means parents may be healthy carriers and brothers or sisters could also be affected or be carriers. Close relatives may also carry the same change without knowing it. This can matter for future pregnancies and for family members who want to understand their own chances of having a child with the condition.
Genetic information
Genetic testing
How you find out about variants
To look for variants in the RNASEH2A gene, RNASEH2A genetic testing usually uses a blood or saliva sample. A lab reads the gene's DNA sequence to check for changes and reports whether a variant is linked to disease, appears benign, or still has uncertain meaning.
When should I consider getting a genetic test?
Genetic testing for the RNASEH2A gene may be considered if a baby or child has signs of a rare inherited inflammatory condition that affects the brain and development, especially when similar problems run in the family. It can also help clarify the cause after abnormal brain scans, seizures, feeding problems, or unexplained developmental delay.
A genetic result is only one part of your health story
Genetic findings can be informative, but the amount they reveal varies with the condition and the kind of variant identified. Over time, the way the body functions is shaped by many factors, including lifestyle, environment, age, and medical history. In some conditions, particularly those affected by many genes, genetic information provides context rather than certainty and makes the most sense when considered with other parts of care. In other situations, a genetic finding may offer a clear answer. In areas like medication response, these results can also help put personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can influence how your body absorbs, breaks down, or responds to medicines. This helps explain why the same drug works well for one person, causes more side effects in another, or seems to do little for someone else. These differences are common and can affect how strongly a treatment works or how sensitive a person is to it.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences shape the way people respond to medications. It looks at connections between genes and drugs to better understand why the same treatment can work differently from one person to another. For many medicines, genes influence either how strongly a drug works or how the body processes it. This information can support more informed, more individualized treatment decisions. If you want to learn more about this topic, more information is available in the LearnHub.
Drugs influenced by the RNASEH2A gene
When should I seek medical advice?
There isn’t yet a broadly confirmed role for this gene in guiding medicine choice or dosing, so questions about side effects, poor treatment response, or medicine safety are best discussed with your doctor. They can review your symptoms, current medicines, and overall health to decide what matters most.
History
RNASEH2A came into focus as scientists worked to understand RNase H enzymes, a group first recognized because they could remove RNA from mixed RNA DNA strands in laboratory studies. In the early 2000s, researchers identified the human RNase H2 complex and confirmed that the RNASEH2A gene encodes its catalytic core, the part that carries out the enzyme’s main activity. Building on this early work, scientists uncovered more about the gene when variants in RNASEH2A were linked to Aicardi-Goutières syndrome, a rare inherited neurologic condition, in 2009. That discovery helped connect basic enzyme research with genetic disease. Over time, descriptions became more precise as studies clarified how RNASEH2A relates to the other RNase H2 genes, RNASEH2B and RNASEH2C. Today, RNASEH2A is best known in medical genetics through this path from bench research to rare disease discovery.